{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:14:15Z","timestamp":1790748855569,"version":"4.1.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1,12]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>High ST2 and TIM3 at day 28 after allogeneic HCT were associated with nonrelapse mortality and overall survival at 2 years. Low day 28 L-Ficolin was associated with VOD\/SOS and high CXCL9 correlated with chronic GVHD.<\/jats:p>","DOI":"10.1182\/blood-2016-08-735324","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T12:59:41Z","timestamp":1478696381000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":83,"title":["Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post\u2013allogeneic HCT"],"prefix":"10.1182","volume":"129","author":[{"given":"Mohammad","family":"Abu Zaid","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;"},{"name":"Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Wu","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent R.","family":"Logan","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;"},{"name":"Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;"},{"name":"Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Won","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111905385889600_B1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111905385889600_B2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood-2014-06-584789","article-title":"High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation","volume":"125","author":"Ponce","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111905385889600_B3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2015-03-636753","article-title":"Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment","volume":"126","author":"McDonald","year":"2015","journal-title":"Blood"},{"issue":"25","key":"2019111905385889600_B4","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","article-title":"Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease","volume":"118","author":"Ferrara","year":"2011","journal-title":"Blood"},{"issue":"16","key":"2019111905385889600_B5","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2012-01-403063","article-title":"Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study","volume":"119","author":"Levine","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2019111905385889600_B6","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","article-title":"Plasma biomarkers of lower gastrointestinal and liver acute GVHD","volume":"119","author":"Harris","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2019111905385889600_B7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2013.06.011","article-title":"A novel soluble form of Tim-3 associated with severe graft-versus-host disease","volume":"19","author":"Hansen","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"2019111905385889600_B8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1470-2045(14)71017-4","article-title":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1\/2 trial","volume":"15","author":"Kennedy","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"2019111905385889600_B9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2013-08-520072","article-title":"Plasma CXCL9 elevations correlate with chronic GVHD diagnosis","volume":"123","author":"Kitko","year":"2014","journal-title":"Blood"},{"issue":"22","key":"2019111905385889600_B10","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1200\/JCO.2015.65.9615","article-title":"Biomarker panel for chronic graft-versus-host disease","volume":"34","author":"Yu","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111905385889600_B11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2019111905385889600_B12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2014-04-567164","article-title":"Tacrolimus\/sirolimus vs tacrolimus\/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT","volume":"124","author":"Cutler","year":"2014","journal-title":"Blood"},{"key":"2019111905385889600_B13","doi-asserted-by":"crossref","DOI":"10.3791\/4247","article-title":"High throughput sequential ELISA for validation of biomarkers of acute graft-versus-host disease","volume-title":"J Vis Exp","author":"Fiema","year":"2012"},{"issue":"12","key":"2019111905385889600_B14","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1074\/jbc.M112.430249","article-title":"Mitochondria and the lectin pathway of complement","volume":"288","author":"Brinkmann","year":"2013","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111905385889600_B15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1432-1327.1999.00615.x","article-title":"Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells","volume":"264","author":"Iwahana","year":"1999","journal-title":"Eur J Biochem"},{"issue":"308","key":"2019111905385889600_B16","doi-asserted-by":"crossref","first-page":"308ra160","DOI":"10.1126\/scitranslmed.aab0166","article-title":"ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci Transl Med"},{"issue":"4","key":"2019111905385889600_B17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J Pathol"},{"issue":"6","key":"2019111905385889600_B18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2007111179","article-title":"CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease","volume":"19","author":"Menke","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2019111905385889600_B19","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2006-12-061408","article-title":"CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation","volume":"110","author":"Piper","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2019111905385889600_B20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0301-472X(03)00198-X","article-title":"Role of CXCR3-induced donor T-cell migration in acute GVHD","volume":"31","author":"Duffner","year":"2003","journal-title":"Exp Hematol"},{"issue":"15","key":"2019111905385889600_B21","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1182\/blood-2008-07-168351","article-title":"Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa","volume":"113","author":"Imanguli","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111905385889600_B22","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bmt.2009.346","article-title":"Differential chemokine expression in chronic GVHD of the conjunctiva","volume":"45","author":"Westekemper","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"2019111905385889600_B23","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2012-02-413260","article-title":"Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD","volume":"120","author":"Croudace","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111905385889600_B24","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"},{"issue":"16","key":"2019111905385889600_B25","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"issue":"24","key":"2019111905385889600_B26","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2015-09-668251","article-title":"Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells","volume":"127","author":"Kariminia","year":"2016","journal-title":"Blood"},{"issue":"24","key":"2019111905385889600_B27","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1182\/blood-2016-04-709543","article-title":"CXCL10: most consistent cGVHD biomarker?","volume":"127","author":"Paczesny","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2019111905385889600_B28","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2019111905385889600_B29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2015-10-612747","article-title":"How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver","volume":"127","author":"McDonald","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111905385889600_B30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","article-title":"A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality","volume":"21","author":"MacMillan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111905385889600_B31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/bmt.2015.261","article-title":"A risk-adapted approach to acute GVHD treatment: are we there yet?","volume":"51","author":"Holtan","year":"2016","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/2\/162\/1400449\/blood735324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/2\/162\/1400449\/blood735324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T10:39:17Z","timestamp":1574159957000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/2\/162\/36077\/Plasma-biomarkers-of-risk-for-death-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-08-735324","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}